Gainers:
Family Dollar Stores, Inc. (FDO) is up nearly 3 percent to $67.85. The company's fourth quarter profit improved from the year-ago period. Net sales rose 10.8 percent and were in-line with Wall Street view. The company forecast fiscal 2013 earnings in-line with analysts' estimate.
Sarepta Therapeutics, Inc. (SRPT) is jumping 103 percent to $30.50. The company announced that the treatment with its exon-skipping compound, eteplirsen, met the primary efficacy endpoint. Meanwhile, the company has received a notice from the U.S. Department of Defense that the Ebola portion of its contract for the advanced development of hemorrhagic fever virus therapeutics was terminated due to funding constraints.
Hanesbrands Inc. (HBI) is up 2 percent to $32.63. The company reaffirmed its 2012 earnings, sales and financial guidance based on consumer and retail market trends through mid-to late September, including the primary back-to-school selling period.
Netflix, Inc. (NFLX) is rising 3 percent to $58.29.
Best Buy Co. Inc. (BBY) is rising more than 3 percent to $17.53.
Decliners:
Monsanto Co. (MON) is down 3 percent to $88.00. The company's fourth quarter loss widened from the previous year period. Net sales for the quarter declined from the year-ago quarter and also missed the consensus estimate. The company also guided its fiscal 2013 earnings below analysts' estimate.
Walgreen Co. (WAG) is falling more than 1 percent to $36.30. The company's September sales decreased 7.8 percent from the year-ago quarter. Total front-end sales decreased 0.4 percent, while comparable store front-end sales decreased 1.5 percent.
Xyratex Ltd. (XRTX) is down 10 percent to $7.80 following the release of its third quarter results.
Antares Pharma Inc. (ATRS) is down 8 percent to $4.05. The company has priced a firm commitment underwritten public offering of 12.50 million of its common shares at $4.00 per share.
For comments and feedback: editorial@rttnews.com